205 related articles for article (PubMed ID: 27535333)
1. Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study.
Pamnani SJ; Sudenga SL; Viscidi R; Rollison DE; Torres BN; Ingles DJ; Abrahamsen M; Villa LL; Lazcano-Ponce E; Salmeron J; Quiterio M; Huang Y; Borenstein A; Giuliano AR
Cancer Res; 2016 Oct; 76(20):6066-6075. PubMed ID: 27535333
[TBL] [Abstract][Full Text] [Related]
2. Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies.
Rosillon D; Baril L; Del Rosario-Raymundo MR; Wheeler CM; Skinner SR; Garland SM; Salmeron J; Lazcano-Ponce E; Vallejos CS; Stoney T; Ter Harmsel B; Lim TYK; Quek SC; Minkina G; McNeil SA; Bouchard C; Fong KL; Money D; Ilancheran A; Savicheva A; Cruickshank M; Chatterjee A; Fiander A; Martens M; Bozonnat MC; Struyf F; Dubin G; Castellsagué X
Cancer Med; 2019 Aug; 8(10):4938-4953. PubMed ID: 31273942
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women.
Kim S; Arduino JM; Roberts CC; Marsico M; Liaw KL; Skjeldestad FE
Sex Transm Dis; 2011 Jul; 38(7):587-97. PubMed ID: 21301390
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of human papillomavirus antibodies in males and females in England.
Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
[TBL] [Abstract][Full Text] [Related]
5. Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men.
Lu B; Viscidi RP; Wu Y; Lee JH; Nyitray AG; Villa LL; Lazcano-Ponce E; da Silva RJ; Baggio ML; Quiterio M; Salmeron J; Smith DC; Abrahamsen ME; Papenfuss MR; Stockwell HG; Giuliano AR
Cancer Res; 2012 Feb; 72(3):676-85. PubMed ID: 22123925
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
[TBL] [Abstract][Full Text] [Related]
7. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
[TBL] [Abstract][Full Text] [Related]
8. A Serological Epidemiological Survey of Antibodies against 4 HPV Subtypes in Uygur Women in Xinjiang.
Husaiyin S; Han L; Mamat H; Husaiyin K; Wang L; Niyazi M
Jpn J Infect Dis; 2016 Jul; 69(4):273-8. PubMed ID: 26255734
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses following incident anal and penile infection with human papillomavirus in teenage men who have sex with men.
Zou H; Tabrizi SN; Grulich AE; Hocking JS; Garland SM; Bradshaw CS; Cornall AM; Fairley CK; Chen MY
Int J Cancer; 2016 Aug; 139(3):639-46. PubMed ID: 26991809
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S
J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of human papillomavirus (HPV) type 6 and 16 vary by anatomic site of HPV infection in men.
Lu B; Viscidi RP; Wu Y; Nyitray AG; Villa LL; Lazcano-Ponce E; Carvalho da Silva RJ; Baggio ML; Quiterio M; Salmerón J; Smith DC; Abrahamsen M; Papenfuss M; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1542-6. PubMed ID: 22761306
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV Infection in Men (HIM) Study.
Ingles DJ; Pierce Campbell CM; Messina JA; Stoler MH; Lin HY; Fulp WJ; Abrahamsen M; Sirak BA; O'Keefe MT; Papenfuss M; Gage C; Carvalho da Silva R; Gonzalez Sosa R; Rojas Juarez O; Villa LL; Lazcano Ponce E; Giuliano AR
J Infect Dis; 2015 Apr; 211(7):1060-7. PubMed ID: 25344518
[TBL] [Abstract][Full Text] [Related]
13. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18.
Villa LL; Ault KA; Giuliano AR; Costa RL; Petta CA; Andrade RP; Brown DR; Ferenczy A; Harper DM; Koutsky LA; Kurman RJ; Lehtinen M; Malm C; Olsson SE; Ronnett BM; Skjeldestad FE; Steinwall M; Stoler MH; Wheeler CM; Taddeo FJ; Yu J; Lupinacci L; Railkar R; Marchese R; Esser MT; Bryan J; Jansen KU; Sings HL; Tamms GM; Saah AJ; Barr E
Vaccine; 2006 Jul; 24(27-28):5571-83. PubMed ID: 16753240
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men.
Lu B; Hagensee ME; Lee JH; Wu Y; Stockwell HG; Nielson CM; Abrahamsen M; Papenfuss M; Harris RB; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):511-6. PubMed ID: 20086109
[TBL] [Abstract][Full Text] [Related]
15. HPV 6/11, 16, 18 seroprevalence in men in two US cities.
Dunne EF; Nielson CM; Hagensee ME; Papenfuss MR; Harris RB; Herrel N; Gourlie J; Abrahamsen M; Markowitz LE; Giuliano AR
Sex Transm Dis; 2009 Nov; 36(11):671-4. PubMed ID: 19809385
[TBL] [Abstract][Full Text] [Related]
16. Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination.
Naud PS; Roteli-Martins CM; De Carvalho NS; Teixeira JC; de Borba PC; Sanchez N; Zahaf T; Catteau G; Geeraerts B; Descamps D
Hum Vaccin Immunother; 2014; 10(8):2147-62. PubMed ID: 25424918
[TBL] [Abstract][Full Text] [Related]
17. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.
Ji J; Sun HK; Smith JS; Wang H; Esser MT; Hu S; Pretorius RG; Chen W; Belinson JL; Qiao YL
BMC Infect Dis; 2012 Jun; 12():137. PubMed ID: 22715915
[TBL] [Abstract][Full Text] [Related]
19. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus (HPV) L1 Serum Antibodies and the Risk of Subsequent Oral HPV Acquisition in Men: The HIM Study.
Pierce Campbell CM; Viscidi RP; Torres BN; Lin HY; Fulp W; Abrahamsen M; Lazcano-Ponce E; Villa LL; Kreimer AR; Giuliano AR
J Infect Dis; 2016 Jul; 214(1):45-8. PubMed ID: 26931445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
